Pentraxin-3 concentration in gingival crevicular fluid
Not Applicable
- Conditions
- Generalized moderate chronic periodontitis.
- Registration Number
- IRCT20190717044253N1
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
25 to 50 years
Patients with moderate periodontitis (patient group)
No history of periodontal disease (control group)
Exclusion Criteria
Systemic conditions such as respiratory and cardiovascular diseases, diabetes mellitus, HIV, chemotherapy, pregnancy or nursing
Antibiotic therapy, medication intake in the past 6 months,
Smokers
Infectious diseases and any sign/symptom of infection.
Periodontal treatment in the past 6 months
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evel of pentraxin-3 in gingival crevicular fluid. Timepoint: At the beginning of the study and 6 weeks after scaling and rootplaning. Method of measurement: enzyme-linked immunosorbent assay.
- Secondary Outcome Measures
Name Time Method